Claudia Bareggi

1.4k total citations
38 papers, 721 citations indexed

About

Claudia Bareggi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Claudia Bareggi has authored 38 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Claudia Bareggi's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Vascular Tumors and Angiosarcomas (4 papers). Claudia Bareggi is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Vascular Tumors and Angiosarcomas (4 papers). Claudia Bareggi collaborates with scholars based in Italy, United States and Netherlands. Claudia Bareggi's co-authors include Massimo Maniezzo, Elena Fagnoni, E Cislaghi, G. Saibene, Tiziana Campa, Carla Ripamonti, Cinzia Brunelli, Erika Rijavec, Alice Indini and Donatella Gambini and has published in prestigious journals such as PLoS ONE, Cancer and Scientific Reports.

In The Last Decade

Claudia Bareggi

34 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Bareggi Italy 12 516 220 211 106 85 38 721
Samuel Jang United States 14 221 0.4× 142 0.6× 61 0.3× 229 2.2× 150 1.8× 33 678
S. Rocca Rossétti Italy 12 206 0.4× 99 0.5× 449 2.1× 200 1.9× 48 0.6× 26 677
Yi‐Jun Kim South Korea 14 166 0.3× 23 0.1× 178 0.8× 144 1.4× 74 0.9× 49 603
Run Fan United States 13 265 0.5× 29 0.1× 123 0.6× 143 1.3× 47 0.6× 25 588
Lydia Gedmintas United States 10 595 1.2× 180 0.8× 217 1.0× 94 0.9× 11 0.1× 16 894
Carrie Ye Canada 10 251 0.5× 71 0.3× 56 0.3× 65 0.6× 22 0.3× 45 393
Didier Mayeur France 12 209 0.4× 24 0.1× 120 0.6× 107 1.0× 32 0.4× 50 390
R. Jyothirmayi United Kingdom 13 120 0.2× 21 0.1× 142 0.7× 124 1.2× 38 0.4× 30 485
Scott W. Bloom United States 7 442 0.9× 15 0.1× 117 0.6× 126 1.2× 33 0.4× 10 554
Xin An China 15 839 1.6× 13 0.1× 183 0.9× 423 4.0× 68 0.8× 29 1.0k

Countries citing papers authored by Claudia Bareggi

Since Specialization
Citations

This map shows the geographic impact of Claudia Bareggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Bareggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Bareggi more than expected).

Fields of papers citing papers by Claudia Bareggi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Bareggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Bareggi. The network helps show where Claudia Bareggi may publish in the future.

Co-authorship network of co-authors of Claudia Bareggi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Bareggi. A scholar is included among the top collaborators of Claudia Bareggi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Bareggi. Claudia Bareggi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noci, Sara, Tania Camboni, Eleonora Mangano, et al.. (2025). Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer. Journal for ImmunoTherapy of Cancer. 13(9). e011526–e011526.
2.
Bramati, Lorenzo, et al.. (2025). Multidisciplinary Perspective of Spread Through Air Spaces in Lung Cancer: A Narrative Review. Cancers. 17(20). 3374–3374.
3.
Ciarmiello, Andrea, Elisabetta Giovannini, Amalia Milano, et al.. (2024). Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?. Journal of Clinical Medicine. 13(9). 2613–2613. 4 indexed citations
4.
5.
Balendra, Vyshnavy, et al.. (2023). High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks. Journal of Personalized Medicine. 13(9). 1325–1325. 20 indexed citations
6.
Denaro, Nerina, Salvatore Alfieri, Alessia Dolci, et al.. (2023). The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer. Cancers. 15(9). 2458–2458. 8 indexed citations
7.
Borella, Paola, Paola Rafaniello Raviele, Gianluca Bonitta, et al.. (2023). Liquid biopsy in non-small cell lung cancer: a meta-analysis of state-of-the-art and future perspectives. Frontiers in Genetics. 14. 1254839–1254839. 8 indexed citations
8.
Florimonte, Luigia, et al.. (2022). 918P Improving TNM staging predictive value with PET/CT imaging features and deep learning model in non-small cell lung cancer. Annals of Oncology. 33. S966–S966. 1 indexed citations
9.
Tomasello, Gianluca, Michele Ghidini, Antonio Ghidini, et al.. (2021). Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2–3 studies. Radiotherapy and Oncology. 164. 13–19. 8 indexed citations
10.
Ghidini, Michele, Alice Indini, Erika Rijavec, et al.. (2021). The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score. Viruses. 13(3). 508–508. 1 indexed citations
11.
Indini, Alice, Erika Rijavec, Michele Ghidini, et al.. (2021). Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review. International Journal of Molecular Sciences. 22(5). 2628–2628. 32 indexed citations
12.
Ciarmiello, Andrea, Luigia Florimonte, Claudia Bareggi, et al.. (2021). 1137P Machine learning radiomics for prediction of survival in non-small cell lung cancer patients studied with PET/CT and FDG. Annals of Oncology. 32. S926–S926. 1 indexed citations
13.
Indini, Alice, Erika Rijavec, Claudia Bareggi, & Francesco Grossi. (2021). Immunotherapy for locally advanced non-small cell lung cancer: current evidence and future perspectives. 3. 25–25. 1 indexed citations
14.
Verde, Nicla La, Elena Collovà, Livio Blasi, et al.. (2020). Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. Clinical Breast Cancer. 21(5). e489–e496. 7 indexed citations
15.
Indini, Alice, Erika Rijavec, Michele Ghidini, et al.. (2020). Coronavirus infection and immune system: An insight of COVID-19 in cancer patients. Critical Reviews in Oncology/Hematology. 153. 103059–103059. 30 indexed citations
16.
Pesenti, Chiara, Laura Fontana, Leda Paganini, et al.. (2018). Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry. Diagnostic Pathology. 13(1). 4–4. 14 indexed citations
17.
Cavalleri, Tommaso, Laura Angelici, Chiara Favero, et al.. (2017). Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease. PLoS ONE. 12(5). e0176680–e0176680. 57 indexed citations
18.
Ganzinelli, Monica, Eliana Rulli, Elisa Caiola, et al.. (2015). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). Scientific Reports. 5(1). 16331–16331. 11 indexed citations
19.
Gullo, Giuseppe, Daniela Bettio, Monica Zuradelli, et al.. (2013). Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy. The Breast. 22(2). 190–193. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Jang Breakdown of academic impact, for papers by S. Rocca Rossétti Breakdown of academic impact, for papers by Yi‐Jun Kim Breakdown of academic impact, for papers by Run Fan Breakdown of academic impact, for papers by Lydia Gedmintas Breakdown of academic impact, for papers by Carrie Ye Breakdown of academic impact, for papers by Didier Mayeur Breakdown of academic impact, for papers by R. Jyothirmayi Breakdown of academic impact, for papers by Scott W. Bloom Breakdown of academic impact, for papers by Xin An
Rankless by CCL
2026